Ashleigh Palmer, President and CEO at Provention Bio, Inc. (PRVB), bought 2,800 shares at $12.83 ($36K) on 2020-08-17, disclosed to the SEC on 2020-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| PRVB | BUY | 2021-12-01 | $25K | — | Filing → |
| PRVB | BUY | 2020-08-18 | $6K | — | Filing → |
| PRVB | BUY | 2019-12-23 | $24K | — | Filing → |